ADCT
Price:
$1.09
Market Cap:
$138.64M
ADC Therapeutics S.A. operates as a commercial-stage biotechnology company, focused on developing antibody-drug conjugates (ADCs) for the treatment of hematological malignancies and solid tumors. Its flagship product, ZYNLONTA, is presently being evaluated in multiple clinical trials: a Phase II study for relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma; a Phase III trial assessing its combination with rituximab for second-line, transplant-ineligible patients with relapsed or refractory DLBCL; and a Phase I trial for relapsed or refractory non-Hodgkin lymphoma (NHL). The company's pipeline also includes camidanlumab tesirine, another ADC, which has complet...[Read more]
Industry
Biotechnology
IPO Date
2020-05-18
Stock Exchange
NYSE
Ticker
ADCT
According to ADC Therapeutics S.A.’s latest financial reports and current stock price. The company's current ROE is 65.27%. This represents a change of 305.86% compared to the average of 16.08% of the last 4 quarters.
The mean historical ROE of ADC Therapeutics S.A. over the last ten years is -33.15%. The current 65.27% ROE has changed -296.90% with respect to the historical average. Over the past ten years (40 quarters), ADCT's ROE was at its highest in in the June 2023 quarter at 569.59%. The ROE was at its lowest in in the March 2023 quarter at -157.55%.
Average
-33.15%
Median
-54.74%
Minimum
-197.77%
Maximum
161.93%
Discovering the peaks and valleys of ADC Therapeutics S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 170.36%
Maximum Annual ROE = 161.93%
Minimum Annual Increase = -Infinity%
Minimum Annual ROE = -197.77%
| Year | ROE | Change |
|---|---|---|
| 2025 | 76.75% | -1.47% |
| 2024 | 77.89% | -51.90% |
| 2023 | 161.93% | -181.88% |
| 2022 | -197.77% | 42.80% |
| 2021 | -138.50% | 88.66% |
| 2020 | -73.41% | -29.95% |
| 2019 | -104.79% | 7.47% |
| 2018 | -97.51% | 170.36% |
| 2017 | -36.07% | -Infinity% |
The current ROE of ADC Therapeutics S.A. (ADCT) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
105.52%
5-year avg
-3.94%
10-year avg
-33.15%
ADC Therapeutics S.A.’s ROE is greater than Omeros Corporation (-54.39%), greater than Neumora Therapeutics, Inc. Common Stock (-181.70%), greater than RAPT Therapeutics, Inc. (-61.81%), greater than Autolus Therapeutics plc (-128.53%), greater than Alumis Inc. Common Stock (-54.63%), greater than Bicycle Therapeutics plc (-35.74%), greater than Lexicon Pharmaceuticals, Inc. (-18.64%), greater than 4D Molecular Therapeutics, Inc. (-36.83%), greater than Lineage Cell Therapeutics, Inc. (-152.10%), greater than Quantum-Si incorporated (-47.35%),
| Company | ROE | Market cap |
|---|---|---|
| -54.39% | $744.02M | |
| -181.70% | $279.78M | |
| -61.81% | $959.26M | |
| -128.53% | $401.88M | |
| -54.63% | $2.89B | |
| -35.74% | $277.58M | |
| -18.64% | $892.83M | |
| -36.83% | $504.99M | |
| -152.10% | $301.65M | |
| -47.35% | $197.62M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ADC Therapeutics S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ADC Therapeutics S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is ADC Therapeutics S.A.'s ROE?
How is the ROE calculated for ADC Therapeutics S.A. (ADCT)?
What is the highest ROE for ADC Therapeutics S.A. (ADCT)?
What is the 3-year average ROE for ADC Therapeutics S.A. (ADCT)?
What is the 5-year average ROE for ADC Therapeutics S.A. (ADCT)?
How does the current ROE for ADC Therapeutics S.A. (ADCT) compare to its historical average?